Wyeth Paying $491M To End Criminal, Civil Rapamune Cases
Wyeth Pharmaceuticals Inc. has agreed to shell out $491 million to end a criminal action as well as civil False Claims Act cases alleging it illegally marketed its immunosuppressive drug Rapamune...To view the full article, register now.
Already a subscriber? Click here to view full article